Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01989676
Brief Title: A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)

First Submitted : October 28, 2013
First Submitted that Met QC Criteria : November 14, 2013
First Posted : November 21, 2013 (Estimate)

Results First Submitted : September 13, 2017
Results First Submitted that Met QC Criteria : December 21, 2017
Results First Posted : January 23, 2018

Certification/Extension First Submitted : July 20, 2017
Certification/Extension First Submitted that Met QC Criteria : July 20, 2017
Certification/Extension First Posted : July 24, 2017

Last Update Submitted that Met QC Criteria : August 3, 2019
Last Update Posted : August 13, 2019